Chiron Real Estate (XRN) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
30 Jun, 2026Executive summary
Mark Decker, Jr. was appointed CEO and President in June 2025, completing a leadership transition focused on growth, value creation, and strategic priorities such as portfolio review and asset recycling.
Rental revenue for Q2 2025 increased to $37.9M, up $3.7M year-over-year, driven by acquisitions and partially offset by dispositions.
Net income improved in Q2 2025, with $0.6M reported versus a $2.0M loss in Q2 2024; six-month net income rose to $4.3M from $0.4M year-over-year.
Emphasis on transparency, improved disclosure, and reaffirmed full year 2025 AFFO guidance.
Financial highlights
Portfolio occupancy as of June 30, 2025, was 94.5%, with 5.2M leasable sq. ft. and annualized base rent of $117.5M.
Q2 2025 FFO was $14.3M ($0.20 per share and unit), and AFFO was $16.6M ($0.23 per share and unit), both up year-over-year.
Dividend reduced from $0.21 to $0.15 per share in Q2 2025, improving coverage and freeing $17M annually for growth and debt repayment.
Year-to-date CapEx and leasing commissions totaled $5.2M, with full-year guidance of $12–$14M.
Net cash provided by operating activities for H1 2025 was $34.4M, up from $33.2M in H1 2024.
Outlook and guidance
Total occupancy expected to end 2025 above 95%, supported by 150,000 sq. ft. of new leases.
Full year 2025 AFFO per share and unit guidance reaffirmed at $0.89 to $0.93, excluding one-time CEO succession costs.
Management expects to refinance the $350M Term Loan A and extend the Revolver maturity in Q4 2025, with no significant adverse changes anticipated.
G&A run rate for the second half of the year expected to be consistent with Q2, excluding one-time transition costs.
Guidance assumes no additional acquisitions or dispositions beyond those completed or announced.
Latest events from Chiron Real Estate
- Q3 2024 featured resilient occupancy, lower net income, and active acquisitions amid market challenges.XRN
Q3 20248 Jul 2026 - Portfolio shift to higher-return senior housing assets and JV unlocks $200M for reinvestment.XRN
Corporate presentation6 Jul 2026 - Q3 2025 net loss from impairment, but FFO/AFFO and rental revenue grew year-over-year.XRN
Q3 202530 Jun 2026 - AFFO guidance reaffirmed as net income rises and portfolio expands despite tenant bankruptcy.XRN
Q1 202530 Jun 2026 - Q2 net loss from property sale, but AFFO, occupancy, and acquisition activity remain strong.XRN
Q2 202430 Jun 2026 - Strong Q4 results and stable AFFO, with acquisitions and JV supporting 2025 growth.XRN
Q4 202430 Jun 2026 - Healthcare REIT registers Series C Preferred and Common Stock for resale by major investors.XRN
Registration filing16 Jun 2026 - $425M in senior housing acquisitions, $100M equity, and 36% dividend cut drive growth.XRN
Q1 202613 May 2026 - Strategic acquisitions and a diversified portfolio drive growth and support a well-covered dividend.XRN
Investor presentation7 May 2026